Hydrolyzable Poly[Poly(Ethylene Glycol) Methyl Ether Acrylate]–Colistin Prodrugs through Copper-Mediated Photoinduced Living Radical Polymerization
- 7 July 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 28 (7) , 1916-1924
Abstract
Through the recently developed copper-mediated photoinduced living radical polymerization (CP-LRP), a novel and well-defined polymeric prodrug of the antimicrobial lipopeptide colistin has been developed. A colistin initiator (Boc5–col–Br2) was synthesized through the modification of colistin on both of its threonine residues using a cleavable initiator linker, 2-(2-bromo-2-methylpropanoyloxy) acetic acid (BMPAA), and used for the polymerization of acrylates via CP-LRP. Polymerization proceeds from both sites of the colistin initiator, and through the polymerization of poly(ethylene glycol) methyl ether acrylate (PEGA480), three water-soluble polymer–colistin conjugates (col–PPEGA, having degrees of polymerization of 5, 10, and 20) were achieved with high yield (conversion of ≥93%) and narrow dispersities (Đ < 1.3) in 2–4 h. Little or no effect on the structure and activity of the colistin was observed during the synthesis, and most of the active colistin can be recovered from the conjugates in vitro within 2 days. Furthermore, in vitro biological analyses including disk diffusion, broth microdilution, and time-kill studies suggested that all of the conjugates have the ability to inhibit the growth of multidrug-resistant (MDR) Gram-negative bacteria, of which col–PPEGA DP5 and DP10 showed similar or better antibacterial performance compared to the clinically relevant colistin prodrug CMS, indicating their potential as an alternative antimicrobial therapy. Moreover, considering the control over the polymerization, the CP-LRP technique has the potential to provide an alternative platform for the development of polymer bioconjugates.Keywords
Funding Information
- Engineering and Physical Sciences Research Council (1367109)
- Leverhulme Trust (ECF/2015-075)
- National Institute of Allergy and Infectious Diseases (R01 AI111965)
- National Health and Medical Research Council (APP1109945)
- Australian Research Council (APP1109945, CE140100036)
This publication has 38 references indexed in Scilit:
- ATRP in the design of functional materials for biomedical applicationsProgress in Polymer Science, 2012
- RAFT polymerization mediated bioconjugation strategiesPolymer Chemistry, 2011
- Renal and neurological side effects of colistin in critically ill patientsAnnals of Intensive Care, 2011
- Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2006
- Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial InfectionsClinical Infectious Diseases, 2005
- Lack of development of new antimicrobial drugs: a potential serious threat to public healthThe Lancet Infectious Diseases, 2005
- Evaluation of colistin as an agent against multi-resistant Gram-negative bacteriaInternational Journal of Antimicrobial Agents, 2005
- HP‐RAFT: A Free‐Radical Polymerization Technique for Obtaining Living Polymers of Ultrahigh Molecular WeightsAngewandte Chemie International Edition, 2004
- Stability of Colistin and Colistin Methanesulfonate in Aqueous Media and Plasma as Determined by High-Performance Liquid ChromatographyAntimicrobial Agents and Chemotherapy, 2003
- The future challenges facing the development of new antimicrobial drugsNature Reviews Drug Discovery, 2002